Navigation Links
Study finds no correlation between primary kidney stone treatment and diabetes

ROCHESTER, Minn. -- A Mayo Clinic study finds no correlation between the use of shock waves to break up kidney stones and the long-term development of diabetes. The study was released Friday during a meeting of the North Central Section of the American Urological Association ( in Rancho Mirage, Calif.

"We did not identify a significant correlation between shockwave lithotripsy and the long-term development of diabetes mellitus," says Matthew Gettman, M.D. (, a Mayo Clinic urologist and co-author of the paper, "Shockwave Lithrotripsy and Diabetes Mellitus: A Population-Based Cohort Study."

"We believe this 'clears the air' on this topic, which has been the subject of debate for some time," Dr. Gettman says.

Among more than 5,200 patients analyzed, 14.1 percent were found to have developed incident diabetes, while just 8 percent were treated with shockwave lithotripsy (, pointing to no significant correlation between the treatment and the incidence of diabetes ( Multiple analytical approaches were used, and researchers controlled for age, gender and obesity.

According to the National Kidney Foundation, 5 percent of Americans will develop stones in the kidney, bladder and/or urinary tract. Shockwave lithotripsy, a nonsurgical technique for treating such stones, uses high-energy shock waves to break stones into tiny fragments small enough for patients to pass in their urine.

While shockwave lithotripsy is the most common treatment for kidney stones, it has been known to affect the pancreas in certain patients. Because of the critical role the pancreas plays in the development of diabetes, there has been some concern that the use of shockwave lithotripsy could cause diabetes.

Contact: Joe Dangor
Mayo Clinic

Related medicine news :

1. New Animal Study Might Explain Jet Lag Differences
2. Cell Phones Dont Raise Brain Cancer Risk, Study Says
3. More Than 1 in 4 U.S. Kids Witness Violence Between Parents: Study
4. Blood-pressure-lowering drug after stroke aids recovery, study finds
5. Study highlights issues faced by friends and family of the suicidal
6. Foreclosure Crisis Threatening Americans Health: Study
7. Car Crash Injury Risk Greater for Women Drivers: Study
8. Unvaccinated Kids Behind Largest U.S. Measles Outbreak in Years: Study
9. New study shows soy protein improves lipid profile in healthy individuals
10. Music Aimed at Teens Often Promotes Drinking: Study
11. Breast Radiation After Lumpectomy Saves Lives: Study
Post Your Comments:
(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to ... between the two groups began in 2014 with Vitalalert pledging a portion of every ... founded in 1954 and is an international Christian-based health organization whose mission is to ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, ... for the Narconon network, announced the release of a new cutting edge recovery program ... organization has been working with drug- and alcohol-addicted individuals with the purpose to free ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... , ... In an ongoing Clinical Study conducted by an independent physician, Andrew ... is evaluating the efficacy of its product and its disinfection protocol. This study is ... May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary ... Periwinkle Pioneers, nominated by the public, will receive special recognition throughout 2016 as ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... 2015 --> ... devices was valued at $11,171.1 million in 2014, and ... 5.7% during 2015 - 2022. The global market is ... of diabetes. In addition, the increase in obese population ... to the growth of the market. Furthermore, technological advancements ...
Breaking Medicine Technology: